Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
2.990
+0.070 (2.40%)
At close: Dec 20, 2024, 4:00 PM
3.183
+0.193 (6.46%)
After-hours: Dec 20, 2024, 6:46 PM EST
Absci Market Cap
Absci has a market cap or net worth of $343.42 million as of December 20, 2024. Its market cap has increased by 55.91% in one year.
Market Cap
343.42M
Enterprise Value
228.34M
1-Year Change
55.91%
Ranking
Category
Stock Price
$2.99
Market Cap Chart
Since the IPO on July 22, 2021, Absci's market cap has decreased from $423.19M to $343.42M, a decrease of -18.85%. That is a compound annual growth rate of -5.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 343.42M | -12.02% |
| Dec 29, 2023 | 390.34M | 101.18% |
| Dec 30, 2022 | 194.03M | -74.44% |
| Dec 31, 2021 | 759.25M | 79.41% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Olema Pharmaceuticals | 338.11M |
| Valneva SE | 337.82M |
| Aquestive Therapeutics | 335.99M |
| Neurogene | 334.83M |
| NeuroPace | 332.51M |
| Spok Holdings | 330.03M |
| Revance Therapeutics | 323.10M |
| Jasper Therapeutics | 322.60M |